| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced or Recurrent Carcinoma of the Uterine Cervix: To Treat or Not To Treat and with What?
|
Thigpen, J. Tate
|
|
2008
|
1 |
2 |
p. 89-90
2 p.
|
artikel
|
| 2 |
Bevacizumab in the Management of Epithelial Ovarian Cancer
|
Garcia, Agustin A.
|
|
2008
|
1 |
2 |
p. 116-119
4 p.
|
artikel
|
| 3 |
CON: Not All Patients with Endometrial Cancer with Extrauterine Disease Should Receive Chemotherapy After Any Indicated Surgery
|
Randall, Marcus E.
|
|
2008
|
1 |
2 |
p. 107-110
4 p.
|
artikel
|
| 4 |
CON: Therapy for a Patient with Platinum–Resistant/Refractory Ovarian Cancer Should Not Be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay
|
Farley, John
|
|
2008
|
1 |
2 |
p. 99-103
5 p.
|
artikel
|
| 5 |
Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology May 30-June 3, 2008; Chicago, IL
|
|
|
2008
|
1 |
2 |
p. 91-95
5 p.
|
artikel
|
| 6 |
Issues in the Design of Ovarian Cancer Trials Evaluating Antineoplastic Agents Not Predicted to Cause Regression of Existing Tumor Masses
|
Markman, Maurie
|
|
2008
|
1 |
2 |
p. 111-115
5 p.
|
artikel
|
| 7 |
Optimizing Management of Recurrent Epithelial Ovarian Cancer with Non–Platinum-Based Chemotherapy
|
Lauraine, Eric Pujade
|
|
2008
|
1 |
2 |
p. 139-140
2 p.
|
artikel
|
| 8 |
Platelet-Derived Growth Factor Pathway Inhibitors in Ovarian Cancer
|
Schmitt, Jordan
|
|
2008
|
1 |
2 |
p. 120-126
7 p.
|
artikel
|
| 9 |
Preoperative Serum Levels of Epidermal Growth Factor Receptor, HER2, and Vascular Endothelial Growth Factor in Malignant and Benign Ovarian Tumors
|
Steffensen, Karina Dahl
|
|
2008
|
1 |
2 |
p. 127-134
8 p.
|
artikel
|
| 10 |
PRO: Patients with Endometrial Carcinoma Involving Extrauterine Disease Should, After Any Indicated Surgery, Receive Chemotherapy
|
Thigpen, J. Tate
|
|
2008
|
1 |
2 |
p. 104-106
3 p.
|
artikel
|
| 11 |
PRO: Therapy for a Patient with Platinum–Resistant/Refractory Recurrent Ovarian Carcinoma Should Be Selected Based on the Result of an In Vitro Chemoresistance Assay
|
Thigpen, J. Tate
|
|
2008
|
1 |
2 |
p. 96-98
3 p.
|
artikel
|
| 12 |
Report on the Gynecologic Oncology Group
|
Alvarez, Ronald David
|
|
2008
|
1 |
2 |
p. 141-142
2 p.
|
artikel
|
| 13 |
The Use of Radiofrequency Ablation in Advanced Ovarian Cancer: Resection and Ablation of Liver Metastases
|
Fleury, Aimee C.
|
|
2008
|
1 |
2 |
p. 135-138
4 p.
|
artikel
|
Tijdschrift beschrijving